Great news indeed. To reduce side effects and so enable higher doses of Docetaxel is a major therapeutic benefit. This reminds me of the advance Don Metcalf brought by discovering CSF in the threatment of leukaemia. Unfortunately Australia lost the patent for this discovery and the benefits went to USA . This time Starpharma and Australia will benefit!
- Forums
- ASX - By Stock
- Ann: DEP Docetaxel Trial Dose Exceeds Common Taxotere Dose Level
Great news indeed. To reduce side effects and so enable higher...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.003(3.30%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.2¢ | 9.4¢ | 9.2¢ | $28.85K | 309.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28383 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 17763 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28383 | 0.092 |
2 | 123413 | 0.091 |
2 | 52750 | 0.090 |
2 | 97420 | 0.089 |
1 | 73255 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 17763 | 2 |
0.099 | 1285 | 1 |
0.100 | 127534 | 5 |
0.105 | 75676 | 4 |
0.110 | 16500 | 2 |
Last trade - 11.22am 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online